6059-29-6

Basic information

• Product Name: [3-[(Benzyl)oxy]-2-pyridinyl]methanol
• Synonyms: [3-[(Benzyl)oxy]-2-pyridinyl]methanol;(3-(Benzyloxy)pyridin-2-yl)methanol;C-(3-benzyloxypyridin-2-yl)methylamine
• CAS NO: 6059-29-6
• Molecular Formula: C₁₃H₁₃NO₂
• Molecular Weight: 215.25
• Mol File: 6059-29-6.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 370.5 °C at 760 mmHg
• Flash Point: 177.9 °C
• Appearance: /
• Density: 1.188
• Vapor Pressure: 3.82E-06mmHg at 25°C
• Refractive Index: 1.599
• CAS DataBase Reference: [3-[(Benzyl)oxy]-2-pyridinyl]methanol(CAS DataBase Reference)
• NIST Chemistry Reference: [3-[(Benzyl)oxy]-2-pyridinyl]methanol(6059-29-6)
• EPA Substance Registry System: [3-[(Benzyl)oxy]-2-pyridinyl]methanol(6059-29-6)

Safety Data

• Hazardous Substances Data: 6059-29-6(Hazardous Substances Data)

Usage

General Description

"[3-[(Benzyl)oxy]-2-pyridinyl]methanol" is a chemical compound with the molecular formula C16H15NO2. It is a member of the alcohol family and contains a benzyl group, a pyridine ring, and a hydroxyl functional group. [3-[(Benzyl)oxy]-2-pyridinyl]methanol is often used as a building block in organic synthesis, particularly in the production of various pharmaceuticals and agrochemicals. It may also have potential applications in medicinal chemistry and drug development due to its structural features. Additionally, it is important to handle this compound with caution and follow proper safety protocols when working with it in a laboratory setting.

InChI:InChI=1/C13H13NO2/c15-9-12-13(7-4-8-14-12)16-10-11-5-2-1-3-6-11/h1-8,15H,9-10H2

Upstream product

• 14173-30-9 3-hydroxy-2-hydroxymethylpyridine hydrochloride 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 
• 14047-53-1 3-hydroxy-2-hydroxymethylpyridine 
• 177559-01-2 3-(benzyloxy)-2-methylpyridine 
• 1121-25-1 2-methyl-3-pyridinol 

Downstream Products

• 94454-57-6 3-(phenylmethoxy)-2-pyridinecarboxaldehyde 
• 839711-82-9 (E)-ethyl 3-(3-(benzyloxy)-N-oxypyridin-2-yl)acrylate 
• 139745-90-7 (E)-ethyl 3-(3-(benzyloxy)-2-pyridinyl)propenoate 
• 647840-35-5 (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-acetoxy-2-benzoyloxy-5,20-epoxy-1-hydroxy-9,10-[(1S)-2-(morpholino)ethylidenedioxy]tax-11-en-13-yl (2R,3S)-3-(3-benzyloxy-2-pyridyl)-3-(tert-butoxycarbonylamino)-2-hydroxypropionate 
• 647840-33-3 (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-acetoxy-2-benzoyloxy-5,20-epoxy-1-hydroxy-9,10-[(1S)-2-propenylidenedioxy]tax-11-en-13-yl (2R,3S)-3-(3-benzyloxy-2-pyridyl)-3-(tert-butoxycarbonylamino)-2-triisopropylsilyloxypropionate 
• 136423-93-3 (3-benzyloxy)-2-pyridinecarboxaldehyde guanylhydrazone sulphate 
• 944445-41-4 3-(benzyloxy)-2-(chloromethyl)pyridine 
• 70381-91-8 2-(3-hydroxypropyl)pyridin-3-ol 
• 70381-92-9 2,3-dihydro-4H-pyrano<3,2-b>pyridine 
• 1438073-62-1 N-(3-chloro-4-fluorophenyl)-6-(3-(hexahydro-2H-pyrano[3,2-b]pyridin-5(3H)-yl)propoxy)-7-methoxyquinazolin-4-amine 

Relevant articles and documents

Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation

Gd-based MRI contrast agents (GBCAs) have come under intense regulatory scrutiny due to concerns of Gd retention and delayed toxicity. Three GBCAs comprising acyclic Gd chelates, the class of GBCA most prone to Gd release, are no longer marketed in Europe

AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE

The present invention relates to the field of medicine. Provided herein are aminoquinazoline derivatives, their salts and pharmaceutical formulations useful in modulating the protein tyrosine kinase activity, and in modulating inter-and/or intra-cellular signaling. Also provided herein are pharmaceutically acceptable compositions comprising the aminoquinazoline compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

Stereoselective synthesis of swainsonines from pyridines

An efficient synthesis of (-)-swainsonine and (-)-2,8a-di-epi-swainsonine was developed starting from readily available 2-pyridinecarbaldehyde and 3-hydroxypyridine. In particular, it was demonstrated that the mixture of simple indolizidines, i.e. lentigi